Klaus Borner
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Parasitology top 5%
- Toxoplasma gondii Research Studies
Papers in
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 20
- Epidemiology 11
- Pneumonia and Respiratory Infections 7
- Herpesvirus Infections and Treatments 4
- Co-authors
- H. Lode (13 shared papers)P. Koeppe (6 shared papers)Annette Lubasch (1 shared paper)Oliver Liesenfeld (4 shared papers)Rainer Müller (4 shared papers)Helmut Hahn (2 shared papers)Oliver Kayser (1 shared paper)Rudolf Fitzner (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Chemotherapy (3 papers)Journal of drug targeting (2 papers)International Journal of Antimicrobial Agents (2 papers)The American Journal of Medicine (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Klaus Borner
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 312
- Parasitology 126
- Molecular Medicine 95
- Pharmaceutical Science 112
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Klaus Borner
This map shows the geographic impact of Klaus Borner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Borner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Borner more than expected).
Fields of papers citing papers by Klaus Borner
This network shows the impact of papers produced by Klaus Borner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Borner. The network helps show where Klaus Borner may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Borner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 212 | |
| 2 | 2000 | 158 | |
| 3 | 2001 | 117 | |
| 4 | 2007 | 74 | |
| 5 | 2001 | 72 | |
| 6 | 2004 | 61 | |
| 7 | 2010 | 54 | |
| 8 | 2009 | 34 | |
| 9 | 1992 | 33 | |
| 10 | 2009 | 32 | |
| 11 | 2002 | 32 | |
| 12 | 2005 | 31 | |
| 13 | 1998 | 30 | |
| 14 | 2008 | 18 | |
| 15 | 2005 | 18 | |
| 16 | 1987 | 17 | |
| 17 | 1970 | 16 | |
| 18 | 1999 | 15 | |
| 19 | 1996 | 12 | |
| 20 | 1999 | 12 |
About Klaus Borner
Klaus Borner is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Herpesvirus Infections and Treatments (4 papers), Epilepsy research and treatment (4 papers), Toxoplasma gondii Research Studies (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). The work is most often cited by research in Pharmacology (312 citations), Parasitology (126 citations), Molecular Medicine (95 citations), Pharmaceutical Science (112 citations) and Applied Microbiology and Biotechnology (16 citations). Klaus Borner has collaborated with scholars based in Germany, United States and France. Frequent co-authors include H. Lode, P. Koeppe, Annette Lubasch, Oliver Liesenfeld, Rainer Müller, Helmut Hahn, Oliver Kayser, Rudolf Fitzner, Olaf Burkhardt and Heike Wulff. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Chemotherapy, Journal of drug targeting, International Journal of Antimicrobial Agents and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.